Literature DB >> 16673062

Osteoradionecrosis of the mandible: minimized risk profile following intensity-modulated radiation therapy (IMRT).

Gabriela Studer1, Stephan Philipp Studer, Roger Arthur Zwahlen, Pia Huguenin, Klaus Wilhelm Grätz, Urs Martin Lütolf, Christoph Glanzmann.   

Abstract

BACKGROUND AND
PURPOSE: Osteoradionecrosis (ON) of the mandible is a serious late complication of high-dose radiation therapy for tumors of the oropharynx and oral cavity. After doses between 60 and 72 Gy using standard fractionation, an incidence of ON between 5% and 15% is reported in a review from 1989, whereas in more recent publications using moderately accelerated or hyperfractionated irradiation and doses between 69 and 81 Gy, the incidence of ON is between < 1% and ~ 6%. Intensity-modulated radiation therapy (IMRT) is expected to translate into a further important reduction of ON. The aim of this descriptive study was to assess absolute and relative bone volumes exposed to high IMRT doses, related to observed bone tolerance. PATIENTS AND METHODS: Between December 2001 and November 2004, 73 of 123 patients treated with IMRT were identified as subgroup "at risk" for ON (> 60 Gy for oropharyngeal or oral cavity cancer). 21/73 patients were treated in a postoperative setting, 52 patients underwent primary definitive irradiation. In 56 patients concomitant cisplatin-based chemotherapy was applied. Mean follow-up time was 22 months (12-46 months). Oral cavity including the mandible bone outside the planning target volume was contoured and dose-volume constraints were defined in order to spare bone tissue. Dose-volume histograms were obtained from contoured mandible in each patient and were analyzed and related to clinical mandible bone tolerance.
RESULTS: Using IMRT with doses between 60 and 75 Gy (mean 67 Gy), on average 7.8, 4.8, 0.9, and 0.3 cm(3) were exposed to doses > 60, 65, 70, and 75 Gy, respectively. These values are substantially lower than when using three-dimensional conformal radiotherapy. The difference has been approximately quantified by comparison with a historic series. Additional ON risk factors of the patients were also analyzed. Only one grade 3 ON of the lingual horizontal branch, treated with lingual decortication, was observed.
CONCLUSION: Using IMRT, only very small partial volumes of the mandibular bone are exposed to high radiation doses. This is expected to translate into a further reduction of ON and improved osseointegration of dental implants.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16673062     DOI: 10.1007/s00066-006-1477-0

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  34 in total

Review 1.  Osteoradionecrosis of the jaws--a current overview--part 1: Physiopathology and risk and predisposing factors.

Authors:  Bruno Ramos Chrcanovic; Peter Reher; Alexandre Andrade Sousa; Malcolm Harris
Journal:  Oral Maxillofac Surg       Date:  2010-03

Review 2.  Organ-sparing radiation therapy for head and neck cancer.

Authors:  XiaoShen Wang; ChaoSu Hu; Avraham Eisbruch
Journal:  Nat Rev Clin Oncol       Date:  2011-07-26       Impact factor: 66.675

3.  Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison.

Authors: 
Journal:  Radiother Oncol       Date:  2017-07-18       Impact factor: 6.280

4.  Successful treatment of a rare case of ameloblastic fibrosarcoma with radiation therapy.

Authors:  Michael Oertel; Gabriele Reinartz; Sergiu Scobioala; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2017-04-25       Impact factor: 3.621

Review 5.  Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies.

Authors:  Douglas E Peterson; Wolfgang Doerr; Allan Hovan; Andres Pinto; Debbie Saunders; Linda S Elting; Fred K L Spijkervet; Michael T Brennan
Journal:  Support Care Cancer       Date:  2010-06-06       Impact factor: 3.603

6.  Compliance with fluoride custom trays in irradiated head and neck cancer patients.

Authors:  Juliette Thariat; Liliane Ramus; Vincent Darcourt; Pierre-Yves Marcy; N Guevara; Guillaume Odin; Gilles Poissonnet; Laurent Castillo; Ali Mohammed Ali; Christian Righini
Journal:  Support Care Cancer       Date:  2011-09-25       Impact factor: 3.603

Review 7.  Osteonecrosis of the jaws: clinicopathologic and radiologic characteristics, preventive and therapeutic strategies.

Authors:  Vassilios Vassiliou; Nikolaos Tselis; Dimitrios Kardamakis
Journal:  Strahlenther Onkol       Date:  2010-04-26       Impact factor: 3.621

8.  Tumor subsites and risk of osteoradionecrosis of the jaw in patients with oral cavity cancer: a national-based cohort study.

Authors:  Pei-Hsun Liao; Chi-Hsiang Chu; Yao-Min Hung; Pei-Ling Tang; Tsu-Jen Kuo
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-02       Impact factor: 2.503

Review 9.  Radiation-related treatment effects across the age spectrum: differences and similarities or what the old and young can learn from each other.

Authors:  Matthew J Krasin; Louis S Constine; Debra L Friedman; Lawrence B Marks
Journal:  Semin Radiat Oncol       Date:  2010-01       Impact factor: 5.934

10.  Outcome in recurrent head neck cancer treated with salvage-IMRT.

Authors:  Gabriela Studer; Klaus W Graetz; Christoph Glanzmann
Journal:  Radiat Oncol       Date:  2008-12-17       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.